Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (71-80 of 282) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotypingRogier A Oldenburg, Karin Kroeze-Jansema, Hanne Meijers-Heijboer, et al.
Cancer Letters|February 11, 2009
Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancerYulia M Ulybina, Ekatherina Sh Kuligina, Nathalia V Mitiushkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
Mutation of SDHB is a cause of hypoxia-related high-altitude paragangliomaNidia Y Cerecer-Gil, Luis E Figuera, Francisco J Llamas, et al.
Cancers|July 2, 2021
<i>RAD51D</i> Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA VariantsElena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, et al.
Journal of Medical Genetics|June 13, 2019
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer familiesInge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, et al.
International Journal of Molecular Sciences|January 28, 2026
Experimental Mis-Splicing Assessment and ACMG/AMP-Guided Classification of 47 <i>ATM</i> Splice-Site VariantsInés Llinares-Burguet, Lara Sanoguera-Miralles, Elena Bueno-Martínez, et al.
BMC Medical Genetics|April 17, 2009
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patientsJean-Pierre Bayley, Anneliese E M Grimbergen, Patrick A van Bunderen, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Breast Cancer Research and Treatment|June 8, 2006
CHEK2 1100delC mutation is frequent among Russian breast cancer patientsElena V Chekmariova, Anna P Sokolenko, Konstantin G Buslov, et al.
Cancer Research|December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesRogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
Pageof 29

Showing results (71-80 of 282) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotypingRogier A Oldenburg, Karin Kroeze-Jansema, Hanne Meijers-Heijboer, et al.
Cancer Letters|February 11, 2009
Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancerYulia M Ulybina, Ekatherina Sh Kuligina, Nathalia V Mitiushkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
Mutation of SDHB is a cause of hypoxia-related high-altitude paragangliomaNidia Y Cerecer-Gil, Luis E Figuera, Francisco J Llamas, et al.
Cancers|July 2, 2021
<i>RAD51D</i> Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA VariantsElena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, et al.
Journal of Medical Genetics|June 13, 2019
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer familiesInge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, et al.
International Journal of Molecular Sciences|January 28, 2026
Experimental Mis-Splicing Assessment and ACMG/AMP-Guided Classification of 47 <i>ATM</i> Splice-Site VariantsInés Llinares-Burguet, Lara Sanoguera-Miralles, Elena Bueno-Martínez, et al.
BMC Medical Genetics|April 17, 2009
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patientsJean-Pierre Bayley, Anneliese E M Grimbergen, Patrick A van Bunderen, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Breast Cancer Research and Treatment|June 8, 2006
CHEK2 1100delC mutation is frequent among Russian breast cancer patientsElena V Chekmariova, Anna P Sokolenko, Konstantin G Buslov, et al.
Cancer Research|December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesRogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
Pageof 29